Header Logo

Connection

ANAIS MALPICA to Carcinoma, Endometrioid

Back to Details
This is a "connection" page, showing publications ANAIS MALPICA has written about Carcinoma, Endometrioid.
ANAIS MALPICA
Connection Strength
4.291
Carcinoma, Endometrioid
  1. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases. Am J Surg Pathol. 2023 06 01; 47(6):635-648.
    View in: PubMed
    Score: 0.703
  2. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers. Int J Gynecol Pathol. 2016 Sep; 35(5):410-8.
    View in: PubMed
    Score: 0.445
  3. How to approach the many faces of endometrioid carcinoma. Mod Pathol. 2016 Jan; 29 Suppl 1:S29-44.
    View in: PubMed
    Score: 0.425
  4. Lymph node counts in endometrial cancer: expectations versus reality. Am J Surg Pathol. 2011 Jun; 35(6):913-8.
    View in: PubMed
    Score: 0.309
  5. Nodal endosalpingiosis in ovarian serous tumors of low malignant potential with lymph node involvement: a case for a precursor lesion. Am J Surg Pathol. 2010 Oct; 34(10):1442-8.
    View in: PubMed
    Score: 0.295
  6. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases. Am J Surg Pathol. 2006 Jul; 30(7):844-9.
    View in: PubMed
    Score: 0.220
  7. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma? Int J Gynecol Pathol. 2006 Jan; 25(1):52-8.
    View in: PubMed
    Score: 0.212
  8. Ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary. Ann Diagn Pathol. 2003 Oct; 7(5):300-5.
    View in: PubMed
    Score: 0.182
  9. SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and Endometrial Carcinomas. Mod Pathol. 2023 02; 36(2):100001.
    View in: PubMed
    Score: 0.173
  10. Endometrial endometrioid adenocarcinoma in a premenopausal woman presenting with metastasis to bone: a case report and review of the literature. Int J Gynecol Pathol. 2002 Jul; 21(3):281-4.
    View in: PubMed
    Score: 0.167
  11. Endometrial cancer recurrence at multiple port sites. Int J Gynecol Cancer. 2020 06; 30(6):893-896.
    View in: PubMed
    Score: 0.143
  12. Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists. Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S25-S39.
    View in: PubMed
    Score: 0.131
  13. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations. Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S40-S63.
    View in: PubMed
    Score: 0.131
  14. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists. Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S64-S74.
    View in: PubMed
    Score: 0.131
  15. Risk factors for recurrence and prognosis of low-grade endometrial adenocarcinoma; vaginal versus other sites. Int J Gynecol Pathol. 2014 May; 33(3):268-73.
    View in: PubMed
    Score: 0.095
  16. The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma. Am J Surg Pathol. 2013 Nov; 37(11):1728-36.
    View in: PubMed
    Score: 0.091
  17. Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma. Mod Pathol. 2011 Sep; 24(9):1262-71.
    View in: PubMed
    Score: 0.077
  18. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries. Int J Gynecol Pathol. 2010 Mar; 29(2):146-56.
    View in: PubMed
    Score: 0.071
  19. High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases. Anal Cell Pathol (Amst). 2010; 33(5):245-55.
    View in: PubMed
    Score: 0.070
  20. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas. Am J Surg Pathol. 2007 Nov; 31(11):1759-63.
    View in: PubMed
    Score: 0.060
  21. Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge. Am J Surg Pathol. 2006 Feb; 30(2):177-84.
    View in: PubMed
    Score: 0.053
  22. The role of hMSH3 and hMSH6 in ovarian endometrioid carcinoma and relationship with microsatellite instability phenotype. Oncol Rep. 2004 Dec; 12(6):1217-9.
    View in: PubMed
    Score: 0.049
  23. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas. Am J Surg Pathol. 2004 Nov; 28(11):1499-505.
    View in: PubMed
    Score: 0.049
  24. Ovarian mixed-epithelial carcinomas with a microcystic pattern and signet-ring cells. Int J Gynecol Pathol. 2001 Oct; 20(4):323-8.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.